Chemed Corporation (CHE) Sets Record High; Strong Momentum for Holders

March 15, 2018 - By Linda Rogers

Investors sentiment decreased to 1.04 in 2017 Q3. Its down 0.14, from 1.18 in 2017Q2. It dived, as 21 investors sold Chemed Corporation shares while 80 reduced holdings. 29 funds opened positions while 76 raised stakes. 15.40 million shares or 0.81% more from 15.27 million shares in 2017Q2 were reported.
Whittier Trust Com Of Nevada Inc holds 500 shares or 0.01% of its portfolio. Bbva Compass Savings Bank owns 3,448 shares or 0.05% of their US portfolio. 131,227 are owned by Principal Financial Gru. Arizona State Retirement System stated it has 0.02% in Chemed Corporation (NYSE:CHE). Pub Employees Retirement System Of Ohio owns 3,781 shares. Contravisory Invest Management holds 0% in Chemed Corporation (NYSE:CHE) or 9 shares. Suntrust Banks Inc reported 1,223 shares. Shell Asset Mgmt Company reported 28,994 shares. Moreover, Pinebridge Investments L P has 0.04% invested in Chemed Corporation (NYSE:CHE). Cardinal Capital Lc Ct accumulated 38,443 shares. Moreover, Advisory Svcs Net Lc has 0% invested in Chemed Corporation (NYSE:CHE). Coldstream Cap accumulated 1,121 shares or 0.03% of the stock. 570,950 were reported by Acadian Asset Mgmt Limited. Private Na stated it has 2,176 shares. Strs Ohio holds 0.01% or 7,700 shares.

Since October 2, 2017, it had 0 insider purchases, and 6 sales for $4.44 million activity. 6,000 shares were sold by MCNAMARA KEVIN J, worth $1.55 million on Thursday, March 1. On Monday, October 2 GRACE PATRICK P sold $100,740 worth of Chemed Corporation (NYSE:CHE) or 500 shares. 450 shares were sold by SAUNDERS DONALD E, worth $117,485.

The stock of Chemed Corporation (NYSE:CHE) reached all time high today, Mar, 15 and still has $305.83 target or 9.00 % above today’s $280.58 share price. This indicates more upside for the $4.54 billion company. This technical setup was reported by If the $305.83 PT is reached, the company will be worth $408.15 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock decreased 0.28% or $0.78 during the last trading session, reaching $280.58. About 95,749 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since March 15, 2017 and is uptrending. It has outperformed by 37.78% the S&P500.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Among 3 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Chemed had 17 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, October 26 the stock rating was maintained by Oppenheimer with “Outperform”. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) on Tuesday, May 30 with “Hold” rating. The firm earned “Sector Perform” rating on Tuesday, November 1 by RBC Capital Markets. The firm earned “Hold” rating on Sunday, July 30 by RBC Capital Markets. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) on Monday, May 2 with “Sector Perform” rating. The rating was maintained by Oppenheimer on Friday, October 27 with “Outperform”. The stock of Chemed Corporation (NYSE:CHE) earned “Buy” rating by Oppenheimer on Tuesday, July 25. RBC Capital Markets maintained the shares of CHE in report on Friday, September 1 with “Hold” rating. The stock has “Hold” rating by RBC Capital Markets on Wednesday, July 5. The stock of Chemed Corporation (NYSE:CHE) has “Hold” rating given on Thursday, October 26 by KeyBanc Capital Markets.

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $4.54 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 47.88 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.